VCEL

35.37

0.65% 0.23

Handel nachbörslich: 35.37

Vericel Corp (VCEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$35.14

Offen:

$34.89

24-Stunden-Volumen:

364.33K

Relative Volume:

0.63

Marktkapitalisierung:

$1.80B

Einnahmen:

$276.26M

Nettoeinkommen (Verlust:

$16.52M

KGV:

114.91

EPS:

0.3078

Netto-Cashflow:

$24.75M

1W Leistung:

+3.94%

1M Leistung:

+8.71%

6M Leistung:

+5.30%

1J Leistung:

-15.82%

1-Tages-Spanne:

$34.83

$35.52

1-Wochen-Bereich:

$32.99

$35.52

52-Wochen-Spanne:

$28.95

$45.97

Vericel Corp Stock (VCEL) Company Profile

Firmenname

Vericel Corp

Sektor

Healthcare (1112)

Branche

Biotechnology (621)

Telefon

(734) 930-5555

Adresse

64 SIDNEY ST., CAMBRIDGE, MA

Mitarbeiter

398

Twitter

@VericelCorp

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

VCEL's Discussions on Twitter

Compare VCEL vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VCEL Vericel Corp	35.37	1.79B	276.26M	16.52M	24.75M	0.3078
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Vericel Corp Stock (VCEL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-17	Herabstufung	BTIG Research	Buy → Neutral
2024-08-09	Eingeleitet	Canaccord Genuity	Buy
2024-06-20	Eingeleitet	TD Cowen	Buy
2024-01-25	Hochstufung	Truist	Hold → Buy
2023-08-08	Hochstufung	BTIG Research	Neutral → Buy
2022-11-10	Herabstufung	BTIG Research	Buy → Neutral
2022-11-09	Herabstufung	Truist	Buy → Hold
2022-10-14	Fortgesetzt	Stephens	Overweight
2021-01-11	Herabstufung	Oppenheimer	Outperform → Perform
2020-12-18	Eingeleitet	Stephens	Overweight
2020-09-17	Eingeleitet	Truist	Buy
2019-10-09	Eingeleitet	H.C. Wainwright	Buy
2019-02-28	Herabstufung	Needham	Buy → Hold
2018-08-08	Bestätigt	Needham	Buy
2018-07-16	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2018-04-04	Eingeleitet	Leerink Partners	Outperform
2018-03-06	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2018-03-06	Bestätigt	Needham	Buy
2018-03-05	Bestätigt	BTIG Research	Buy
2017-06-21	Eingeleitet	BTIG Research	Buy
2017-03-13	Bestätigt	Needham	Buy
2016-12-22	Eingeleitet	Piper Jaffray	Overweight
2016-11-09	Bestätigt	Needham	Buy
2016-04-05	Herabstufung	BofA/Merrill	Buy → Neutral
2016-03-11	Hochstufung	Needham	Hold → Buy

Alle ansehen

Vericel Corp Aktie (VCEL) Neueste Nachrichten

01:20 AM

VCEL Maintains Buy Rating -- Price Target Lowered to $42 by Trui - GuruFocus

01:20 AM

09:27 AM

Truist Cuts Price Target on Vericel to $42 From $48, Keeps Buy Rating - marketscreener.com

09:27 AM

08:05 AM

Vericel Corporation (VCEL) secures FDA approval for commercial manufacturing of MACI - MSN

08:05 AM

Apr 14, 2026

Critical Limb Ischemia Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Baxter, Ixaka, Hemostemix Inc., Caladrius Biosciences, Vericel Corporation, Helixmith, Lifecells, LLC - Barchart.com

Apr 14, 2026

Apr 11, 2026

Assessing Vericel (VCEL) Valuation After BARDA Awards Up To US$197 Million NexoBrid Contract - simplywall.st

Apr 11, 2026

Apr 10, 2026

Q3 2025 Vericel Corp Earnings Call Transcript - GuruFocus

Apr 10, 2026

Apr 08, 2026

Winners Losers: What are the future prospects of Vericel Corporation2026 Major Catalysts & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Weekly Trades: Is Vericel Corporation part of any ETF2026 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Jonathan Mark Hopper Sells 3,472 Shares of Vericel (NASDAQ:VCEL) Stock - MarketBeat

Apr 06, 2026

Vericel (VCEL) CMO sells 3,472 shares after option exercise under 10b5-1 plan - Stock Titan

Apr 06, 2026

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines - Cantech Letter

Apr 06, 2026

After islet transplants, 10 diabetes patients stopped using insulin - Stock Titan

Apr 06, 2026

Aberdeen Group plc Has $21.03 Million Stock Position in Vericel Corporation $VCEL - MarketBeat

Apr 06, 2026

Analysts Set Vericel Corporation (NASDAQ:VCEL) Price Target at $56.00 - Defense World

Apr 06, 2026

Apr 04, 2026

Vericel Corporation (VCEL) Stock forecasts - Yahoo Finance UK

Apr 04, 2026

VCEL SEC FilingsVericel 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 04, 2026

Allspring Global Investments Holdings LLC Cuts Position in Vericel Corporation $VCEL - marketbeat.com

Apr 04, 2026

Apr 03, 2026

Vericel Corporation (VCEL) Stock Price, News, Quote & History - Yahoo Finance

Apr 03, 2026

Vericel Corporation (VCEL) Stock Forecasts - Yahoo Finance

Apr 03, 2026

Vericel Corporation (NASDAQ:VCEL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 03, 2026

Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com India

Apr 03, 2026

Apr 02, 2026

Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com

Apr 02, 2026

Vericel (VCEL) Secures Lucrative Contract with Health and Human Services - GuruFocus

Apr 02, 2026

MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative

Apr 02, 2026

U.S. stockpile plans include NexoBrid under BARDA deal worth up to $197M - Stock Titan

Apr 02, 2026